DUPHALAC Drug Patent Profile
✉ Email this page to a colleague
When do Duphalac patents expire, and what generic alternatives are available?
Duphalac is a drug marketed by Solvay and is included in one NDA.
The generic ingredient in DUPHALAC is lactulose. There are twenty drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the lactulose profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Duphalac
A generic version of DUPHALAC was approved as lactulose by PHARM ASSOC on July 30th, 1996.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DUPHALAC?
- What are the global sales for DUPHALAC?
- What is Average Wholesale Price for DUPHALAC?
Summary for DUPHALAC
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 28 |
| Clinical Trials: | 4 |
| Patent Applications: | 3,594 |
| DailyMed Link: | DUPHALAC at DailyMed |
Recent Clinical Trials for DUPHALAC
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| RenJi Hospital | Phase 4 |
| Bogomolets National Medical University | N/A |
| CD Pharma India Pvt. Ltd. | Phase 2/Phase 3 |
US Patents and Regulatory Information for DUPHALAC
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Solvay | DUPHALAC | lactulose | SOLUTION;ORAL | 072372-001 | Mar 22, 1989 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
